Table 1.
Demographics and Characteristics of Patients with Incident Neovascular Age-Related Macular Degeneration in 2008 and 2018
| Variable | 2008 (n = 28 518) | 2018 (n = 38 852) |
|---|---|---|
| Sex, no. (%) | ||
| Male | 9279 (32.5) | 13 960 (35.9) |
| Female | 19 239 (67.5) | 24 892 (64.1) |
| Age, yrs | ||
| No. (%) | 28 518 (100) | 38 852 (100) |
| Mean (SD) | 78.8 (8.1) | 81.2 (7.9) |
| Median (interquartile range) | 80.0 (75.0–84.0) | 82.0 (76.0–87.0) |
| Range | 50.0–106.0 | 50.0–106.0 |
| Comorbidities, Charlson comorbidity index∗ | ||
| No. | 28 518 | 38 852 |
| Mean (SD) | 0.8 (1.2) | 0.9 (1.4) |
| Ocular comorbidities, no., (%) | ||
| Cataract surgery† | — | 18 494 (47.6) |
| Treated dry-eye disease‡ | — | 11 783 (30.3) |
| Treated ocular hypertension§|| | — | 6714 (17.3) |
| Nonocular comorbidities (2018 only), no. (%) | ||
| Hypertension|| | — | 26 986 (69.5) |
| Diabetes | — | 4954 (12.8) |
| Myocardial infarction | — | 3519 (9.1) |
| Congestive heart failure | — | 4022 (10.4) |
| Stroke | — | 4444 (11.4) |
| Dementia | — | 1512 (3.9) |
| Renal disease | — | 2757 (7.1) |
| Nonmetastatic cancer | — | 7925 (20.4) |
SD = standard deviation; — = data not available.
∗
In 2018.
†
Cataract surgery reported from 2008 through 2018.
‡
Treated in 2018.
§
Including glaucoma.
||
Patients treated with antihypertensive medications.